Starling Oncology STLNW
NASDAQ STLNW
$0.04 -0.01 (-21.32%)
As of: Sep 9, 2026 · 12:49 PM EDT

Starling Oncology (STLNW) Net Margin (QoQ) (2021 - 2026)

Analysis

Starling Oncology (STLNW) Net Margin (QoQ) (2021 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Davita 11.90 Bn 11.21 Bn 1.16 Bn
2 RadNet 5.52 Bn 4.79 Bn 88.08 Mn
3 Fresenius Medical Care AG 4.79 Bn 4.09 Bn 1.52 Bn
4 Concentra Group Holdings Parent 4.28 Bn 4.12 Bn 192.10 Mn
5 Privia Health 2.57 Bn 2.16 Bn -
6 Pediatrix Medical 2.15 Bn 1.74 Bn -
7 Progyny 2.12 Bn 1.89 Bn 89.30 Mn
8 Surgery Partners 1.82 Bn 1.61 Bn 622.10 Mn
9 U S Physical Therapy 1.17 Bn 1.14 Bn 41.94 Mn
10 Starling Oncology 4.13 Mn -36.96 Mn 27.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -369.00
Mar 31, 2026 311.00
Dec 31, 2025 556.00
Sep 30, 2025 160.00
Jun 30, 2025 372.00
Mar 31, 2025 -460.00
Dec 31, 2024 244.00
Sep 30, 2024 -37.00
Jun 30, 2024 815.00
Mar 31, 2024 85.00
Dec 31, 2023 -63.00
Sep 30, 2023 -17.00
Jun 30, 2023 1,831.00
Mar 31, 2023 -2,396.00
Dec 31, 2022 -1,130.00
Sep 30, 2022 484.00
Jun 30, 2022 -4,391.00
Mar 31, 2022 5,396.00
Dec 31, 2021 -1,833.00
Sep 30, 2021 1,162.00